Prospects for the computational humanization of antibodies and nanobodies
To be viable therapeutics, antibodies must be tolerated by the human immune system. Rational approaches to reduce the risk of unwanted immunogenicity involve maximizing the ‘humanness’ of the candidate drug. However, despite the emergence of new discovery technologies, many of which start from entir...
Những tác giả chính: | Gordon, GL, Raybould, MIJ, Wong, A, Deane, CM |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Frontiers Media
2024
|
Những quyển sách tương tự
-
Computationally profiling peptide: MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies
Bằng: Raybould, MIJ, et al.
Được phát hành: (2023) -
Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodies
Bằng: Robinson, SA, et al.
Được phát hành: (2021) -
Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling
Bằng: Raybould, MIJ, et al.
Được phát hành: (2024) -
SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker
Bằng: Schneider, C, et al.
Được phát hành: (2021) -
Structure-aware tools for the development of therapeutic antibodies from natural immunoglobulins
Bằng: Raybould, MIJ
Được phát hành: (2020)